¼¼°èÀÇ DNA ½ÃÄö½Ì ½ÃÀå
DNA Sequencing
»óǰÄÚµå : 1528032
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 392 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

DNA ½ÃÄö½Ì ½ÃÀåÀº 2030³â±îÁö 171¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2023³â¿¡ 78¾ï ´Þ·¯·Î ÃßÁ¤µÈ DNA ½ÃÄö½Ì ½ÃÀåÀº 2030³â¿¡´Â 171¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÌ°í ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº 11.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. DNA ½ÃÄö½Ì ¼Ò¸ðǰÀº º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÌ¸ç º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 11.5%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½Ã 75¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. DNA ½ÃÄö½Ì Àåºñ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 31¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 15.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ DNA ½ÃÄö½Ì ½ÃÀåÀº 2023³â 31¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 25¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº 15.9%ÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº °¢°¢ 8.8%¿Í 9.5%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) ¾à 9.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è DNA ½ÃÄö½Ì ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

DNA ½ÃÄö½Ì¶õ ¹«¾ùÀΰ¡, ¿Ö º¯ÇõÀ» °¡Á®¿À´Â °ÍÀΰ¡?

DNA ¼­¿­Àº DNA ºÐÀÚ ³»ÀÇ ´ºÅ¬·¹¿ÀƼµåÀÇ Á¤È®ÇÑ ¼ø¼­¸¦ °áÁ¤ÇÏ´Â °úÁ¤ÀÔ´Ï´Ù. DNA »ç½½¿¡¼­ 4°³ÀÇ ¿°±â(¾Æµ¥´Ñ, ±¸¾Æ´Ñ, ½ÃÅä½Å, Ƽ¹Î)ÀÇ ¼ø¼­¸¦ °áÁ¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â ¸ðµç ¹æ¹ý°ú ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. DNAÀÇ ¿°±â¼­¿­À» ½Å¼ÓÇϰí Àú·ÅÇÏ°Ô °áÁ¤ÇÏ´Â ´É·ÂÀº »ý¹°ÇÐ ¿¬±¸¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ä¼ÒÀ̸ç, °úÇÐÀÚµéÀº »ý¹°°ú ¹ÙÀÌ·¯½ºÀÇ ¹ß»ý, ±â´É, ¹ø½ÄÀ» À¯µµÇÏ´Â À¯ÀüÀÚÀÇ Ã»»çÁøÀ» °üÂû ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ö ÀÖ½À´Ï´Ù. Áö³­ ¼ö½Ê³âµ¿¾È, DNA ½ÃÄö½Ì ±â¼úÀÇ Áøº¸´Â À¯ÀüüÇÐ ºÐ¾ß¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×°í, ¸¹Àº Áúº´ÀÇ À¯ÀüÀû ±â¹Ý, Á¾ÀÇ ÁøÈ­, Áý´Ü °£ÀÇ À¯ÀüÀû º¯ÀÌÀÇ È®Àο¡ ´ëÇÑ ±íÀº ÀλçÀÌÆ®·Î À̾îÁ³½À´Ï´Ù.

DNA ½ÃÄö½ÌÀÇ ±â¼úÀº ¾î¶»°Ô Áøº¸Çߴ°¡?

DNA ½ÃÄö½ÌÀÇ ±â¼ú ¹ßÀüÀº Sanger ½ÃÄö½Ì°ú °°Àº ¹æ¹ýÀ» Æ÷ÇÔÇÑ 1 ¼¼´ë ½ÃÄö½Ì¿¡¼­ ¼ö¹é¸¸ °³ÀÇ ÀÛÀº DNA ´ÜÆíÀÇ ½ÃÄö½Ì¸¦ º´·Ä·Î ¼öÇàÇÏ¿© DNA ½ÃÄö½Ì°ú °ü·ÃµÈ ½Ã°£°ú ºñ¿ëÀ» Å©°Ô ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. Â÷¼¼´ë ½ÃÄö½Ì(NGS)¿¡ ´ëÇÑ ±ËÀûÀ» °ÅÀÇ µû¶ó ¿Ô½À´Ï´Ù. NGS Ç÷§ÆûÀº Á¤È®¼º, ¼Óµµ ¹× °¡°ÝÀ» Çâ»ó½Ã۰í Àüü À¯Àüü ½ÃÄö½Ì ¹× °³º°È­ À¯ÀüüÇÐ¿Í °°Àº ´ë±Ô¸ð ÇÁ·ÎÁ§Æ®¸¦ ´õ ¸¹Àº ¿¬±¸ÀÚ ¹× ÀÓ»óÀÇ¿¡°Ô ½ÇÇöÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â ±Þ¼ÓÇÑ Çâ»óÀ» ÀÌ·ç¾ú½À´Ï´Ù. ³×. ¶ÇÇÑ, 1ºÐÀÚ ½Ç½Ã°£ ½ÃÄö½Ì ±â¼úÀ» Æ÷ÇÔÇÑ 3¼¼´ë ½ÃÄö½Ì ±â¼úÀÇ °³¹ßÀº DNA »ùÇÃÀÇ ÁõÆøÀ» ÇÊ¿ä·Î ÇÏÁö ¾Ê°í, º¸´Ù ºü¸£°í Á¤È®ÇÑ ½ÃÄö½Ì ±â´ÉÀ» Á¦°øÇÔÀ¸·Î½á ÀÌ ºÐ¾ß¿¡ ´õ¿í Çõ¸íÀ» °¡Á®¿Ã °ÍÀ» ¾à¼ÓÇÕ´Ï´Ù. Çϰí ÀÖ½À´Ï´Ù.

DNA ½ÃÄö½ÌÀÇ ÁÖ¿ä ¿ëµµ´Â?

DNA ½ÃÄö½ÌÀÇ ÀÀ¿ëÀº ´Ù¾çÇÏ¸ç ´Ù¾çÇÑ ºÐ¾ß¿¡ Àû¿ëµË´Ï´Ù. ÇコÄɾî´Â À¯Àü¼º ÁúȯÀÇ Áø´Ü, ¾ÏÀ¸·Î À̾îÁú ¼ö ÀÖ´Â µ¹¿¬º¯ÀÌÀÇ ½Äº°, °³ÀÎÀÇ À¯ÀüÀû üÁú¿¡ ±Ù°ÅÇÑ Ä¡·á ¹æÄ§ÀÇ °áÁ¤¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ³ó¾÷ ºÐ¾ß¿¡¼­ DNA ½ÃÄö½ÌÀº ½Ä¹°ÀÇ À¯ÀüÀÚ ±¸Á¶¸¦ Á¤È®ÇÏ°Ô º¯È­½ÃÅ´À¸·Î½á °í¼öÀ²·Î ÇØÃæ¿¡ °­ÇÑ ÀÛ¹°À» ¸¸µå´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ¹ýÀÇÇп¡¼­´Â ½ÃÄö½ÌÀ» ÅëÇØ DNAÀÇ ¹Ì¼¼ »ùÇÿ¡¼­ ³ôÀº Á¤È®µµ·Î °³ÀÎÀ» È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ȯ°æ °úÇÐÀÚµéÀº DNA ½ÃÄö½ÌÀ» »ç¿ëÇÏ¿© »ý¹° ´Ù¾ç¼ºÀ» ¿¬±¸Çϰí, Áý´Ü À¯ÀüÇÐÀ» ÀÌÇØÇϰí, ȯ°æ º¯È­°¡ »ýŰèÀÇ À¯Àü ¹°Áú¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÃßÀûÇÕ´Ï´Ù. °¢ ¾ÖÇø®ÄÉÀ̼ÇÀº º¹ÀâÇÑ »ý¹°ÇÐÀû ½Ã½ºÅÛÀÇ ÀÌÇØ¿Í °ü¸®¸¦ ÁøÇàÇÏ´Â µ¥ DNA ½ÃÄö½Ì ±â¼úÀÌ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù´Â °ÍÀ» º¸¿©ÁÝ´Ï´Ù.

DNA ½ÃÄö½Ì ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃÊ·¡µÈ´Ù

DNA ½ÃÄö½Ì ½ÃÀåÀÇ ¼ºÀåÀº ±Þ¼ÓÇÑ ±â¼ú Áøº¸, ºñ¿ë Àý°¨, ´Ù¾çÇÑ ºÐ¾ß·ÎÀÇ ÀÀ¿ë È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. °³º° Ä¡·á °èȹÀ» Á¶Á¤Çϱâ À§ÇØ À¯ÀüÀÚ Á¤º¸¿¡ Å©°Ô ÀÇÁ¸ÇÏ´Â Á¤¹ÐÀÇ·áÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀÔ´Ï´Ù. °Ô´Ù°¡ Á¤ºÎ¿Í ¹Î°£ ÀÚ±Ý Áö¿øÀ» ÅëÇÑ ¼¼°èÀûÀÎ À¯ÀüÀÚ ¿¬±¸ Ȱµ¿ÀÇ È°¼ºÈ­´Â ÷´Ü ½ÃÄö½Ì ¼Ö·ç¼Ç ¼ö¿ä¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. DNA ½ÃÄö½Ì¸¦ ÀÌ¿ëÇÑ °³ÀÎÈ­µÈ °Ç°­ Æò°¡¿Í °¡°è ¼­ºñ½º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¼ÒºñÀÚ Çൿµµ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ COVID-19 ÆÒµ¥¹ÍÀº ¹ÙÀÌ·¯½º µ¹¿¬º¯ÀÌÀÇ È®Àΰú ÃßÀû¿¡ À־ ½Å¼ÓÇÑ ½ÃÄö½Ì ±â¼úÀÇ Á߿伺À» ºÎ°¢½Ã۰í, ¼¼°èÀÇ °Ç°­ °úÁ¦¿¡ ´ëÀÀÇϴµ¥ À־ DNA ½ÃÄö½ÌÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ºÎ°¢½ÃÄ×½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº DNA ½ÃÄö½Ì ½ÃÀåÀÇ Áö¼ÓÀûÀÎ È®´ë¿Í Çõ½Å¿¡ ¹ÚÂ÷¸¦ °¡Çϰí À¯Àüü ¿¬±¸¿¡¼­ °¡Àå ¿ªµ¿ÀûÀÎ ºÐ¾ß Áß Çϳª°¡ µÇ°í ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 76°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global DNA Sequencing Market to Reach US$17.1 Billion by 2030

The global market for DNA Sequencing estimated at US$7.8 Billion in the year 2023, is expected to reach US$17.1 Billion by 2030, growing at a CAGR of 11.8% over the analysis period 2023-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. Growth in the DNA Sequencing Instruments segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 15.9% CAGR

The DNA Sequencing market in the U.S. is estimated at US$3.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 15.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global DNA Sequencing Market - Key Trends & Drivers Summarized

What Is DNA Sequencing and Why Is It Transformative?

DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The ability to sequence DNA quickly and affordably has become a pivotal factor in biological research, enabling scientists to observe the genetic blueprint that guides the development, functioning, and reproduction of living organisms and viruses. Over the past few decades, advancements in DNA sequencing technologies have revolutionized the field of genomics, leading to profound insights into the genetic bases of many diseases, the evolution of species, and identification of genetic variability among populations.

How Has Technology Advanced in DNA Sequencing?

Technological advancements in DNA sequencing have largely followed the trajectory from first-generation sequencing, which includes methods like Sanger sequencing, to next-generation sequencing (NGS), which allows for sequencing of millions of small fragments of DNA in parallel, significantly reducing the time and cost associated with DNA sequencing. NGS platforms have undergone rapid enhancements that have increased accuracy, speed, and affordability, making large-scale projects like whole-genome sequencing and personalized genomics feasible for more researchers and clinicians. Additionally, the development of third-generation sequencing technologies, which include single-molecule real-time sequencing techniques, promises to further revolutionize the field by offering even faster and more accurate sequencing capabilities without the need for amplification of DNA samples.

What Are the Major Applications of DNA Sequencing?

The applications of DNA sequencing are extensive and varied across multiple fields. In healthcare, it is used for diagnosing genetic disorders, identifying mutations that may lead to cancer, and guiding treatment decisions based on an individual’s genetic makeup. In agriculture, DNA sequencing assists in creating high-yield, pest-resistant crops by enabling precise alterations to the genetic structure of plants. Furthermore, in forensic science, sequencing can identify individuals with high accuracy from minute samples of DNA. Environmental scientists use DNA sequencing to study biodiversity, understand population genetics, and track the effects of environmental changes on genetic material in ecosystems. Each application demonstrates the significant impact of DNA sequencing technologies in advancing our understanding and management of complex biological systems.

Growth in the DNA Sequencing Market Is Driven by Several Factors

The growth in the DNA sequencing market is driven by several factors, including rapid technological advancements, decreasing costs, and expanding applications across various fields. The increasing adoption of precision medicine, which relies heavily on genetic information to tailor individual treatment plans, is a major growth driver. Furthermore, the global rise in genetic research activities, bolstered by government and private funding, contributes significantly to the demand for advanced sequencing solutions. Consumer behavior also influences market growth, as there is a growing interest in personalized health assessments and ancestry services, which utilize DNA sequencing. Additionally, the COVID-19 pandemic highlighted the importance of rapid sequencing technologies in identifying and tracking virus mutations, underscoring the critical role of DNA sequencing in responding to global health challenges. These factors collectively fuel the ongoing expansion and innovation within the DNA sequencing market, making it one of the most dynamic areas in genomics research.

Select Competitors (Total 76 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â